Open Access

[Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer

  • Authors:
    • Baisong Lou
    • Xin Zhou
  • View Affiliations

  • Published online on: July 29, 2016     https://doi.org/10.3892/ijmm.2016.2693
  • Pages: 1312-1312
  • Copyright: © Lou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2016
Volume 38 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lou B and Zhou X: [Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer. Int J Mol Med 38: 1312-1312, 2016.
APA
Lou, B., & Zhou, X. (2016). [Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer. International Journal of Molecular Medicine, 38, 1312-1312. https://doi.org/10.3892/ijmm.2016.2693
MLA
Lou, B., Zhou, X."[Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer". International Journal of Molecular Medicine 38.4 (2016): 1312-1312.
Chicago
Lou, B., Zhou, X."[Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer". International Journal of Molecular Medicine 38, no. 4 (2016): 1312-1312. https://doi.org/10.3892/ijmm.2016.2693